Search results

8 in 10 think health research is very important, but confidence is lower among people from ethnic minorities.

The HRA has welcomed two new agreement templates that will make it easier for life-changing medicine and vaccine research and development to take place across different parts of the UK.

Following the trial of a training webinar for researchers and stakeholders who are new to the HRA Approval process, we are pleased to announce two more dates for 'Applying for HRA Approval – getting it right first time'.

As part of our commitment to continuously improving the support we provide to the research community, we are introducing a process to improve the quality and consistency of research applications involving ionising radiation. As part of this process, we are recruiting a panel of HRA Radiation Assurance reviewers to assist us in reaching our goals and support the UK wide process. These will be Lead Clinical Radiation Experts (CREs) and Medical Physics Expert (MPEs) whose role will be to review studies.

As part of our commitment to continuously improving the support we provide to the research community, we are nearing the imminent roll out of Pharmacy Assurance and Radiation Assurance.

HRA chair Jonathan Montgomery will be giving evidence to the Science and Technology Select Committee on Tuesday 30 January.

Janet Wisely has been awarded an OBE in the New Year Honours list. She is recognised for services to health and social care research.

A new chair has been appointed to the Confidentiality Advisory Group (CAG). Dr Tony Calland, a former GP and current CAG vice chair of the group, will replace current chair Dr Mark Taylor in January 2018.

NHS England has launched a consultation looking at how arrangements for research in the NHS could be simplified.

We are looking to increase our CAG membership from April 2018. As one of the CAG’s voluntary members, you will robustly assess applications within our regulatory framework and developed principles to advise whether the activity is in the public interest. We are keen to recruit a diverse set of both lay and expert members from a variety of backgrounds. You could be a member of the public, a patient representative, a member of a consumer group, a healthcare professional, or a member of a professional regulatory body or an academic/research institution.

Three new HRA eLearning modules are now available.

The procedures for safety reporting will vary depending on your type of study.

If your research project involves direct contact with patients, the Research Ethics Committee will want to know how you intend to identify potential participants. There are a number of things to consider including confidentiality and information governance.

Earlier this summer the HRA published its annual report. Among the detailed review of twelve months’ of work, there are some particularly interesting statistics that we’d like to share:

One of the first steps in deciding which approvals you need for your project is to determine whether it is classed as research, and therefore whether it should be managed as such. The responsibility for determining whether a project is classed as research lies with the managing organisation. For studies that are determined to be research, the managing organisation would then accept the role of sponsor.